Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Beguin

Showing results (11-20 of 242) with videos related to

Pageof 25
Sort By:
Cytotherapy|March 17, 2010
Spontaneous and granulocyte–colony-stimulating factor-enhanced marrow response and progenitor cell mobilization in mice after myocardial infarctionMarie Delgaudine, André Gothot, Yves Beguin
The New England Journal of Medicine|August 29, 2003
Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantationFrederic Baron, Marie-Françoise Dresse, Yves Beguin
European Journal of Haematology|January 13, 2006
Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantationPascale Frère, Maguy Pereira, Georges Fillet, et al.
Seminars in Nuclear Medicine|August 16, 2005
Evaluation of therapy for lymphomaGuy Jerusalem, Roland Hustinx, Yves Beguin, et al.
Revue Medicale De Liege|February 15, 2024
[How I manage polycythemia]Gérôme Lombardo, Kaoutar Hafraoui, Yves Beguin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftmentFrédéric Baron, Pascale Frère, Georges Fillet, et al.
European Journal of Haematology|February 24, 2006
Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cellsNancy Van Overstraeten-Schlögel, Yves Beguin, André Gothot
British Journal of Haematology|September 27, 2003
Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusionFrédéric Baron, Pascale Frère, Georges Fillet, et al.
Cytotherapy|October 8, 2013
Neuropeptides to replace serum in cryopreservation of mesenchymal stromal cells?Alexandra Briquet, Amélie Halleux, Chantal Lechanteur, et al.
Hematology (Amsterdam, Netherlands)|September 24, 2002
Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantationFrédéric Baron, Etienne Baudoux, Georges Fillet, et al.
Pageof 25

Showing results (11-20 of 242) with videos related to

Sort By:
Pageof 25
Cytotherapy|March 17, 2010
Spontaneous and granulocyte–colony-stimulating factor-enhanced marrow response and progenitor cell mobilization in mice after myocardial infarctionMarie Delgaudine, André Gothot, Yves Beguin
The New England Journal of Medicine|August 29, 2003
Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantationFrederic Baron, Marie-Françoise Dresse, Yves Beguin
European Journal of Haematology|January 13, 2006
Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantationPascale Frère, Maguy Pereira, Georges Fillet, et al.
Seminars in Nuclear Medicine|August 16, 2005
Evaluation of therapy for lymphomaGuy Jerusalem, Roland Hustinx, Yves Beguin, et al.
Revue Medicale De Liege|February 15, 2024
[How I manage polycythemia]Gérôme Lombardo, Kaoutar Hafraoui, Yves Beguin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftmentFrédéric Baron, Pascale Frère, Georges Fillet, et al.
European Journal of Haematology|February 24, 2006
Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cellsNancy Van Overstraeten-Schlögel, Yves Beguin, André Gothot
British Journal of Haematology|September 27, 2003
Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusionFrédéric Baron, Pascale Frère, Georges Fillet, et al.
Cytotherapy|October 8, 2013
Neuropeptides to replace serum in cryopreservation of mesenchymal stromal cells?Alexandra Briquet, Amélie Halleux, Chantal Lechanteur, et al.
Hematology (Amsterdam, Netherlands)|September 24, 2002
Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantationFrédéric Baron, Etienne Baudoux, Georges Fillet, et al.
Pageof 25